PRR20G

Across TCGA pan-cancer cohorts, PRR20G RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated PRR20G data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher PRR20G RNA is associated with worse overall survival. In most high-consensus cancer types, elevated PRR20G expression acts as an unfavorable survival marker, although some lineages such as SKCM and OV show a favorable association.

ACC, SKCM, and BRCA are the cancer types where PRR20G RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	II,III,IV	0.161	0.635	<.001	102	view →
SKCM	OS	Quartile	All	0.468	0.291	<.001	87	view →
BRCA	OS	Tertile	III,IV	0.690	0.868	<.001	81	view →
UVM	OS	Tertile	II,III,IV	0.213	0.718	.002	81	view →
PAAD	OS	Median	All	0.281	0.488	.003	52	view →
LIHC	OS	Tertile	All	0.340	0.641	<.001	45	view →
KIRC	OS	Median	All	0.757	0.852	.005	24	view →
LUSC	DFS	Quartile	III,IV	0.205	0.495	.008	21	view →
HNSC	DFS	Median	All	0.560	0.691	.004	20	view →
UCEC	DFS	Median	All	0.794	0.869	.007	18	view →
KIRP	DFS	Quartile	II,III,IV	0.609	0.833	.028	17	view →
OV	DFS	Quartile	IV	0.673	0.372	.016	16	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

PRR20G–ACC (OS)

Open the ACC breakdown →